Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response
Phase of Trial: Phase IV
Latest Information Update: 24 Dec 2018
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
- 03 Oct 2018 Planned number of patients changed from 300 to 200.
- 07 Mar 2018 Status changed from not yet recruiting to recruiting.
- 14 Nov 2017 New trial record